title: Recurrence of anti-GBM disease 8 years after renal transplantation.
authors.affiliation: Division of Nephrology, University Health Network, Toronto, Ontario, Canada.
authors.forename: Mukesh
authors.initials: M
authors.lastname: Khandelwal
authors.forename: Brendan B
authors.initials: BB
authors.lastname: McCormick
authors.forename: Ginette
authors.initials: G
authors.lastname: Lajoie
authors.forename: Joan
authors.initials: J
authors.lastname: Sweet
authors.forename: Edward
authors.initials: E
authors.lastname: Cole
authors.forename: Daniel C
authors.initials: DC
authors.lastname: Cattran
mesh_terms: D019867:Anti-Glomerular Basement Membrane Disease / Q000150:complications* / Q000175:diagnosis; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000601:surgery*; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000379:methods; D008775:Methylprednisolone / Q000008:administration & dosage*; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage*; D012008:Recurrence; D018570:Risk Assessment; D013997:Time Factors; D014184:Transplantation, Homologous; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D011241:Prednisone; D008775:Methylprednisolone